Cornerstone Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cornerstone Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,683	Closed	-$261K	–	447
2022 Q1	$261K	Sell	5,683 -833	-13%	-$39.7K	0.03%	395
2021 Q4	$403K	Sell	6,516 -20,108	-76%	-$1.39M	0.04%	327
2021 Q3	$1.99M	Buy	26,624 +987	+4%	+$82.8K	0.21%	107
2021 Q2	$2.37M	Buy	25,637 +1,140	+5%	+$96.9K	0.25%	88
2021 Q1	$2.17M	Buy	24,497 +10,451	+74%	+$1.04M	0.26%	84
2020 Q4	$1.31M	Buy	14,046 +10,541	+301%	+$840K	0.16%	117
2020 Q3	$223K	Buy	+3,505	New	+$205K	0.03%	353

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Cornerstone Wealth Management's ARKG Position: Q2 2022 in Review

Cornerstone Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 5,683 shares — an estimated $261K sold.

Cornerstone Wealth Management first reported a position in ARKG in Q3 2020 and held it in 7 quarters. The position peaked at $2.37M in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

Cornerstone Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
Cornerstone Wealth Management sold 5,683 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $261K.
Cornerstone Wealth Management first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 7 quarters.
Cornerstone Wealth Management's ARK Genomic Revolution ETF position peaked at $2.37M in Q2 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Cornerstone Wealth Management's 13F filing for Q2 2022, filed 4 Aug 2022.